Ensign Peak Advisors Inc Increases Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Ensign Peak Advisors Inc grew its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 21.6% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 414,019 shares of the company’s stock after purchasing an additional 73,427 shares during the quarter. Ensign Peak Advisors Inc owned approximately 0.48% of HealthEquity worth $35,688,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in the business. Lindbrook Capital LLC increased its holdings in HealthEquity by 22.7% during the first quarter. Lindbrook Capital LLC now owns 698 shares of the company’s stock valued at $57,000 after buying an additional 129 shares during the last quarter. O Shaughnessy Asset Management LLC raised its holdings in HealthEquity by 3.9% in the 1st quarter. O Shaughnessy Asset Management LLC now owns 5,219 shares of the company’s stock worth $426,000 after purchasing an additional 197 shares during the period. Nisa Investment Advisors LLC lifted its position in HealthEquity by 7.5% during the second quarter. Nisa Investment Advisors LLC now owns 2,854 shares of the company’s stock valued at $246,000 after purchasing an additional 198 shares in the last quarter. Capstone Investment Advisors LLC grew its holdings in HealthEquity by 7.0% during the fourth quarter. Capstone Investment Advisors LLC now owns 3,710 shares of the company’s stock valued at $246,000 after purchasing an additional 243 shares during the period. Finally, Campbell & CO Investment Adviser LLC increased its position in HealthEquity by 3.2% in the fourth quarter. Campbell & CO Investment Adviser LLC now owns 8,195 shares of the company’s stock worth $543,000 after buying an additional 254 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

Insider Buying and Selling

In other HealthEquity news, Director Frank Corvino sold 7,705 shares of the stock in a transaction on Monday, July 8th. The shares were sold at an average price of $81.89, for a total transaction of $630,962.45. Following the completion of the transaction, the director now owns 6,070 shares in the company, valued at $497,072.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, CEO Jon Kessler sold 32,326 shares of the business’s stock in a transaction that occurred on Monday, June 24th. The stock was sold at an average price of $82.83, for a total transaction of $2,677,562.58. Following the transaction, the chief executive officer now owns 232,176 shares of the company’s stock, valued at approximately $19,231,138.08. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Frank Corvino sold 7,705 shares of the stock in a transaction on Monday, July 8th. The shares were sold at an average price of $81.89, for a total value of $630,962.45. Following the sale, the director now owns 6,070 shares in the company, valued at approximately $497,072.30. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 75,031 shares of company stock worth $6,103,625. Insiders own 2.20% of the company’s stock.

Analysts Set New Price Targets

HQY has been the subject of a number of recent research reports. KeyCorp boosted their price objective on HealthEquity from $95.00 to $100.00 and gave the company an “overweight” rating in a research note on Wednesday, June 5th. Robert W. Baird upped their price target on shares of HealthEquity from $98.00 to $104.00 and gave the stock an “outperform” rating in a research report on Tuesday, June 4th. Raymond James raised their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Friday, June 7th. Bank of America dropped their target price on shares of HealthEquity from $105.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, September 4th. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $92.00 price target on shares of HealthEquity in a report on Wednesday, September 4th. One investment analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $103.83.

HealthEquity Stock Performance

NASDAQ:HQY opened at $79.53 on Friday. The company has a market cap of $6.92 billion, a price-to-earnings ratio of 86.45, a PEG ratio of 1.19 and a beta of 0.52. HealthEquity, Inc. has a 1 year low of $61.81 and a 1 year high of $88.26. The stock’s 50 day simple moving average is $76.17 and its two-hundred day simple moving average is $79.32. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.